Clinical Practice Guideline for Adequate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea.
10.5124/jkma.2007.50.9.830
- Author:
Yoon Koo KANG
1
Author Information
1. Devision of Oncology / Department of Internal Medicine, Ulsan University College of Medicine, Korea. ykkang@amc.seoul.kr
- Publication Type:Practice Guideline ; Original Article
- Keywords:
Guideline;
GIST;
Diagnosis;
Surgery;
Imatinib;
Sunitinib
- MeSH:
Consensus;
Diagnosis*;
Gastrointestinal Stromal Tumors*;
Humans;
Imatinib Mesylate;
Incidence;
Korea*;
Medical Oncology;
Prevalence;
Signal Transduction
- From:Journal of the Korean Medical Association
2007;50(9):830-841
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Despite the rarity in incidence and prevalence, gastrointestinal stromal tumor (GIST) has emerged as a distinct pathogenetic entity, and the clinical management of GIST has been evolving very rapidly due to the recent recognition of its oncogenic signal transduction pathway and the introduction of new molecular-targeted therapy. Successful management of GIST in localized and advanced stages requires a multidisciplinary approach firmly based on accurate histopathologic diagnosis. However, standardized guidelines for the management of Korean GIST patients do not exist. This study was performed to provide a guideline for standardized diagnosis and treatment for GIST in Korea. Expert panel members of the Korean GIST Study Group (KGSG) thoroughly reviewed the relevant literature including European Society of Medical Oncology and National Comprehensive Cancer Network guidelines and shared their experience and opinions to make a consensus on twenty-five topics related with pathologic diagnosis, surgical management, and medical treatment of GIST. The consensus described in this article was presented as the basis for a guideline of diagnosis and treatment for patients with GIST that would be used to facilitate the optimal clinical practice in Korea.
